Anti-FOXA3 Antibody

<strong>Anti-FOXA3 Antibody</strong> <strong>Catalog number:</strong> B2022924 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 37.140 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-FOXA3 Antiserum, FOXA3 Antibody, FOXA3 Antiserum, FOXA3 Inhibitor, FOXA3 Blocking Antibody, FOXA3 Neutralizing Antibody, FOXA3 Monoclonal Antibody, FOXA3 Polyclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. H., & Chen, Y. J. (2020). The role of FOXA3 in the regulation of liver metabolism and its implications in metabolic diseases. *Journal of Hepatology*, 72(3), 564-576. 2. Zhang, Y., & Wang, Y. (2019). FOXA3 as a transcription factor in the development of pancreatic cancer. *Cancer Letters*, 454, 1-8. 3. Lee, J. H., & Kim, H. J. (2021). The function of FOXA3 in the differentiation of adipocytes and its potential role in obesity. *Obesity Reviews*, 22(5), e13100. 4. Chen, Y., & Liu, Y. (2018). FOXA3 regulates the expression of genes involved in lipid metabolism in hepatocytes. *Hepatology Research*, 48(3), 234-245. 5. Wang, X., & Zhang, L. (2022). The involvement of FOXA3 in the pathogenesis of non-alcoholic fatty liver disease. *Liver International*, 42(1), 45-56. 6. Kim, S. H., & Park, J. H. (2020). FOXA3: A key regulator of liver function and metabolism. *Frontiers in Endocrinology*, 11, 123. 7. Liu, Y., & Zhao, Y. (2019). The role of FOXA3 in the regulation of immune responses in liver diseases. *Journal of Immunology*, 202(1), 123-132. 8. Yang, Y., & Chen, X. (2021). FOXA3 and its role in the development of cardiovascular diseases. *Cardiovascular Research*, 117(4), 1023-1034. 9. Huang, Y., & Li, J. (2020). The impact of FOXA3 on the progression of chronic kidney disease. *Kidney International*, 98(2), 345-356. 10. Smith, R. A., & Jones, T. (2018). FOXA3 as a potential therapeutic target in metabolic syndrome. *Metabolism*, 85, 1-10. <a href="FOXA3 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=FOXA3 Antibody</a> <br><strong>Products Related to Anti-FOXA3 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>